Agios Pharmaceuticals, Inc. (AGIO) Financials
AGIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 937.1 million | 126.1 million |
2023-09-30 | 1.0 billion | 120.4 million |
2023-06-30 | 1.1 billion | 120.9 million |
2023-03-31 | 1.2 billion | 114.8 million |
AGIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -72.7 million | 13.8 million |
2023-09-30 | -79.5 million | 9.1 million |
2023-06-30 | -66.7 million | 11.7 million |
2023-03-31 | -95.6 million | 10.1 million |
AGIO Net Income
No data available :(
AGIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 776.9 million | - | 72.0 million |
2023-09-30 | 872.4 million | - | 75.5 million |
2023-06-30 | 946.9 million | - | 78.9 million |
2023-03-31 | 1.0 billion | - | 82.3 million |
AGIO Shares Outstanding
AGIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 234000 | 76.1 million | 35.3 million | - |
2023-09-30 | 17.9 million | 81.8 million | 25.8 million | - |
2023-06-30 | 3000 | 68.9 million | 30.4 million | - |
2023-03-31 | 399000 | 67.3 million | 28.4 million | - |
AGIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 7.1 million | 2.0 million |
2023-09-30 | 7.4 million | 633000 |
2023-06-30 | 6.7 million | 1.1 million |
2023-03-31 | 5.6 million | 554000 |
AGIO
Price: $31.49
52 week price:
Earnings Per Share: -6.33 USD
P/E Ratio: -5.89
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 44002
Ebitda: -88.5 millionMarket Capitalization: 1.6 billion